Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.46)
# 3,329
Out of 4,863 analysts
50
Total ratings
54.84%
Success rate
-5.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $136 → $147 | $134.01 | +9.69% | 5 | Apr 17, 2025 | |
| PODD Insulet | Maintains: Overweight | $305 → $322 | $306.59 | +5.03% | 4 | Feb 21, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $11.07 | +80.67% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $20.04 | +309.18% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $121.11 | +104.77% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $172.10 | +59.79% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $519.04 | -34.69% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.65 | +130.77% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $2.98 | +807.56% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $92.16 | +20.44% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $83.00 | +73.19% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $100.14 | -44.08% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $93.77 | -21.08% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $74.82 | +2.47% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $17.91 | +402.65% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $58.86 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Apr 17, 2025
Maintains: Overweight
Price Target: $136 → $147
Current: $134.01
Upside: +9.69%
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $306.59
Upside: +5.03%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $11.07
Upside: +80.67%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $20.04
Upside: +309.18%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $121.11
Upside: +104.77%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $172.10
Upside: +59.79%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $519.04
Upside: -34.69%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.65
Upside: +130.77%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $2.98
Upside: +807.56%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $92.16
Upside: +20.44%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $83.00
Upside: +73.19%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $100.14
Upside: -44.08%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $93.77
Upside: -21.08%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $74.82
Upside: +2.47%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $17.91
Upside: +402.65%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $58.86
Upside: -